Patients with meningococcaemia had lower serum concentrations of important inhibitors than did patients with localised meningitic infection. Within the coccaemic group, those who died had the lowest values, notably of antithrombin III and x2macroglobulin (and also of C3).
the sera of Nigerian patients suffering from meningococcal infection of varied severity.
Patients with meningococcaemia had lower serum concentrations of important inhibitors than did patients with localised meningitic infection. Within the coccaemic group, those who died had the lowest values, notably of antithrombin III and x2macroglobulin (and also of C3).
The clinical end-result of meningococcal infection may be related to the degree of disequilibrium of the linked system of proteolytic control induced by the meningococcal endotoxin.
A previous study (Greenwood et al., 1976) of epidemic meningococcal infection suggested that complement activation was important in the development of the meningococcaemic form of the disease. Once complement activation has been achieved, its subsequent amplification may largely determine the course of the infection with at least three mechanisms playing a part. First, the C3b product itself amplifies complement activation by the alternative pathway; such amplification is controlled by C3b inactivator (C3b INA) (Lachmann and Nicol, 1973) and the $1H inhibitor (Fearon et al., 1976) . Secondly, the C567 byproduct of activation will lyse cells and platelets locally and release from them lysosomal proteases and thromboplastic materials. The released neutral proteases are able to split C3 and activate the alternative pathway (Schorlemmer and Allison, 1976) . Thirdly, thrombin formed as a result of endotoxic activation of the coagulation pathway can cleave C3 (Bokisch et al., 1969) . The later appearance of plasmin would also result in further activation by splitting of C1 or C3 (Ratnoff and Naff, 1967) .
A number of proteolytic inhibitors in plasma could interrupt this amplification. The sera of Nigerian children suffering from epidemic type A meningoReceived for publication 8 June 1978 coccal infection were therefore examined to determine to what extent the concentrations of these inhibitors correlated with the severity of the disease.
Patients and methods
Randomly selected patients with group A meningococcal disease were studied during an epidemic that affected northern Nigeria in 1977. Sera from 67 patients were studied. Thirty-two patients had meningococcaemia without meningitis, 11 meningitis with group A antigen detectable in the serum by countercurrent immunoelectrophoresis (antigen positive), and 24 meningitis without detectable antigenaemia (antigen negative). Twelve of the patients with meningococcaemia (38 %) and two of the patients with meningitis (6%) died. Samples were also examined from 24 relatives of patients with the disease seen in Zaria in 1975. Children attending outpatients with minor ailments provided control samples.
The mean age in years (± 1 SD) of the different groups of subjects were: acute meningococcaemia, 6-0 ± 2-5; acute meningitis (Ag + ve), 8-8 ± 50 ; acute meningitis (Ag -ve), 107 ± 6-2; convalescents, 11-0 ± 3-7; relatives, 12-7 ± 4-5; and controls, 1 3 2 ± 5 4. Patients with meningococcaemia were significantly younger than patients with meningitis and controls (P < 0O001 for both).
An electroimmunoassay technique (Ryley et al., 1975) (Greenwood et al., 1971 (Table) .
Mean [CT INH] were significantly raised in both Ag + ve and Ag -ve meningitis patients (P < 0 02 and < 0 05, respectively) but not in patients with meningococcaemia (Fig. Ic) .
Antithrombin III [AT III] was significantly depressed (P < 0'001) in patients with meningococcaemia but not in patients with meningitis (Fig. Id) . Coccaemic patients who died had a significantly lower (P < 0-005) mean [AT III] than patients who survived (Table) .
Other protease inhibitors Each of the four major inhibitors behaved differently.
[oiCI] was significantly increased in patients with°1 In comparison between the fatal and non-fatal groups:**** P < 0005 *** < 0-025 ** P < 001 *P < 0<05 coccaemia and meningitis (Fig. le) . This increase, however, was not so great (P < 0 01) in patients with coccaemia as in patients with meningitis.
[caiTI] was significantly raised in patients with meningitis but not in patients with coccaemia ( Fig.  If) .
[I-a-TI] was significantly reduced in all groups. A decrease in the mean serum [a2M] was found in patients with meningococcaemia ( Fig. 1h) , this reduction being due to the low concentrations found in patients who subsequently died (Table) . In convalescence, an increase (P < 0-01) was found only with this inhibitor (Fig. 1h) .
Other acute-phase reactants The behaviour of (x1AGP was similar to that of ocTI, being significantly increased only in patients with meningitis (Fig. ii) . Significantly raised [CRP] was found in all groups (Fig. lj) but meningococcaemic patients had a significantly lower concentration than patients with meningitis (P < 0-001).
Antigen titre
Circulating antigen was detected in 22 of the patients with meningococcaemia. The mean titre in patients who died was significantly higher than in the survivors (Table) .
RELATIVES
Mean serum concentrations of C3, C3b INA, CT INH, AT III, cx1CI, oxTI, I-cx-TI, X2M, and cxlAGP in relatives of patients with meningococcal infections did not differ significantly from those of controls.
CONTROLS
The absolute values of control sera were (as mg/dl): C3, 85-7 ± 21-4; C1 INH, 24-9 ± 8-1; AT III, 40 2 ± 8.5; (xCI, 57-4 ± 12-2; oxiTI, 191-0 ± 66-6; I-cx-TI, 63-4 + 19'9, 012M, 341-0 ± 95 (Baugh et al., 1976 ) from leucocyte lysosomal granules.
atiCI and CRP are known to be early reactants in the acute phase (Laurell and Jeppsson, 1975a) . They showed greater rises in meningitis patients than in coccaemic patients, suggesting that the coccaemic patients become seriously ill before these proteins reach their highest values. The mean serum [012M] was significantly reduced in fatal meningococcaemia but increased in convalescent patients, suggesting that there may have been an increased production and consumption of this inhibitor in all groups; once endotoxin ceases to induce enzyme release, the normal [a2M] is surpassed because supply temporarily exceeds demand.
The pattern with [1-ax-TI] was quite different, it being reduced in all types of meningococcal infection.
The precise function of this inhibitor in vivo has not been established but these observations would suggest an intravascular in addition to the already proposed mucosal role (Laurell and Jeppsson, 1975b The findings are consistent with the notion that the rate of protease release by endotoxin is important in determining the outcome of meningococcal infection; if the rate is so great as to overwhelm the responding rise in proteolytic inhibitors, the control of proteolysis may be fatally upset.
As well as being affected more directly by endotoxin, important cascades will be activated also by the released proteases and cascade products. Loss of control of the cascades, especially at local sites (Heimburger et al., 1971) , will be further accentuated because of the broad specificities of many protease inhibitors (Laurell, 1974; Moroi and Aoki, 1977) . These inhibit enzymes of different cascades as well as otherwise unrelated proteases (Fig. 2) . Thus, for example, an inhibitor imbalance initiated by proteases released from leucocyte granules may indirectly result in reduced inhibition of kallikrein and thrombin and so end in permeability and coagulation changes. In fatal meningococcaemia, AT III was indeed terminally diminished and associated with shock and collapse to which reduced inhibition of the permeability-altering kallikrein system may also have contributed. Because of these relationships, the stability of proteolytic equilibrium can be seen to affect susceptibility to endotoxin. Any influence either lessening the inhibitor concentrations or increasing the amount of proteases released would tilt the balance towards initial susceptibility and subsequent development of endotoxin shock. proteolytic control. 
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